UBLYXI
Dead / Abandoned — Abandoned — failure to respond (as of 28 Mar 2019)
What this means for you
This application is over — abandoned 13 Mar 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87530509
- Mark type
- Stylized text
- Filed
- 17 Jul 2017
- Published for opposition
- 21 Nov 2017
- Abandoned
- 13 Mar 2019
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer
Owner
- TG Therapeutics, New York, NY, US
- TG Therapeutics, New York, NY, US
Prosecution history
- 28 Mar 2019 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 28 Mar 2019 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 12 Sept 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Sept 2018 — NON-FINAL ACTION E-MAILED
- 12 Sept 2018 — SU - NON-FINAL ACTION - WRITTEN
- 11 Sept 2018 — ASSIGNED TO EXAMINER
- 14 Aug 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2018 — USE AMENDMENT FILED
- 09 Aug 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 16 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Nov 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Nov 2017 — PUBLISHED FOR OPPOSITION
- 01 Nov 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Oct 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER